Agency Forms Undergoing Paperwork Reduction Act Review, 32703-32704 [2017-14912]
Download as PDF
<![CDATA[
Federal Register / Vol. 82, No. 135 / Monday, July 17, 2017 / Notices
32703
The total annualized burden for this
study is 2,016 hours. There are no costs
to respondents other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Number of
responses per
respondent
Incident case ...................................................
1,511
1
1
Incident case in 2016 who complete survey ..
823
Prevalent case ................................................
776
1
1
1
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–14913 Filed 7–14–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30 Day–17–17NE]
asabaliauskas on DSKBBXCHB2PROD with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
VerDate Sep<11>2014
17:45 Jul 14, 2017
Jkt 241001
Form name
Medical Inventory ...........................................
Initial Participant Survey Incident case (adult
and parent).
Physical Exam ................................................
Specimen collection .......................................
Initial Participant Survey, Prevalent case
(adult and parent).
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
Survey of Engineered Nanomaterial
Occupational Safety and Health
Practices—New—National Institute for
Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
As mandated in the Occupational
Safety and Health Act of 1970 (PL 91–
596), NIOSH’s mission is to conduct
research and investigations on workrelated disease and injury and to
disseminate information for preventing
identified workplace hazards (Sections
20 (a)(1) and (d)). This dual
responsibility recognizes the need to
translate research into workplace
application if it is to impact worker
safety and well-being. The goal of this
project is to assess the relevance and
impact of NIOSH’s contribution to
guidelines and risk mitigation practices
for safe handling of engineered
nanomaterials in the workplace. The
intended use of this data is to inform
NIOSH’s research agenda to enhance its
relevance and impact on worker safety
and health in the context of engineered
nanomaterials.
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
Average
burden
per response
5/60
10/60
1.5
20/60
10/60
The research under this project will
survey companies who manufacture,
distribute, fabricate, formulate, use or
provide services related to engineered
nanomaterials. The analysis will
describe the survey sample, response
rates, and types of company by industry
and size. Further analysis will focus on
identifying the types of engineered
nanomaterials being used in industry
and the types of occupational safety and
health practices being implemented.
The analysis will be used to develop a
final report which evaluates the
influence of NIOSH products, services,
and outputs on industry occupational
safety and health practices.
Under this project, the following
activities and data collections will be
conducted:
(1) Company Pre-calls. Sampled
companies will be contacted to identify
the person who will complete the
survey and to ascertain whether or not
the company handles engineered
nanomaterials.
(2) Survey. A web-based
questionnaire, with a mail option, will
be administered to companies. The
purpose of the survey is to learn directly
from companies about their use of
NIOSH materials and their occupational
safety and health practices concerning
engineered nanomaterials.
A sample of 600 companies will be
compiled from lists of industry
associations, research reports, marketing
databases, and web-based searches. Of
the 600 selected companies we
anticipate that 500 will complete the
survey within two years. The company
pre-call is expected to require five
minutes to complete. The survey is
expected to require 20 minutes to
complete; including the time it may take
respondents to look-up and retrieve
needed information. The estimated
annualized burden hours for the
respondents’ time to participate in this
information collection is 109 hours.
E:\FR\FM\17JYN1.SGM
17JYN1
32704
Federal Register / Vol. 82, No. 135 / Monday, July 17, 2017 / Notices
There are no costs to the responders
other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Form name
Receptionist ............................................................................
Occupational health and safety specialists .............................
Industrial Production Managers ..............................................
Natural Sciences Managers ....................................................
Pre-call ...................................
Survey ....................................
Survey ....................................
Survey ....................................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–14912 Filed 7–14–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–17–17AMP; Docket No. CDC–2017–
0057]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
ACTION:
Notice with comment period.
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection entitled ‘‘Evaluation of the
SAMHSA Naloxone Education and
Distribution Program.’’ CDC will use the
information collected to evaluate the
program ‘‘Substance Abuse and Mental
Health Services Agency (SAMHSA)
Grants to Prevent Prescription Drug/
Opioid Overdose-Related Deaths.’’ The
program was recently funded to
improve access to treatment for opioid
use disorders, reduce opioid related
deaths, and strengthen drug misuse
prevention efforts.
SUMMARY:
asabaliauskas on DSKBBXCHB2PROD with NOTICES
Number of
respondents
VerDate Sep<11>2014
17:45 Jul 14, 2017
Jkt 241001
Written comments must be
received on or before September 15,
2017.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2017–
0057 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
Please note: All public comment
should be submitted through the
Federal eRulemaking portal
(Regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact LeRoy A.
Richardson, Information Collection
Review Office, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE., MS–D74, Atlanta, Georgia
30329; phone: 404–639–7570; Email:
omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
DATES:
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
300
100
75
75
1
1
1
1
Avgerage
burden per
response
(in hours)
5/60
20/60
20/60
20/60
previously approved information
collection before submitting the
collection to OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information.
Proposed Project
Evaluation of the SAMHSA Naloxone
Education and Distribution Program—
New—National Center for Injury
Prevention and Control (NCIPC),
Centers for Disease Control and
Prevention (CDC).
E:\FR\FM\17JYN1.SGM
17JYN1
]]>Agencies
[Federal Register Volume 82, Number 135 (Monday, July 17, 2017)]
[Notices]
[Pages 32703-32704]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-14912]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30 Day-17-17NE]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.
Proposed Project
Survey of Engineered Nanomaterial Occupational Safety and Health
Practices--New--National Institute for Occupational Safety and Health
(NIOSH), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
As mandated in the Occupational Safety and Health Act of 1970 (PL
91-596), NIOSH's mission is to conduct research and investigations on
work-related disease and injury and to disseminate information for
preventing identified workplace hazards (Sections 20 (a)(1) and (d)).
This dual responsibility recognizes the need to translate research into
workplace application if it is to impact worker safety and well-being.
The goal of this project is to assess the relevance and impact of
NIOSH's contribution to guidelines and risk mitigation practices for
safe handling of engineered nanomaterials in the workplace. The
intended use of this data is to inform NIOSH's research agenda to
enhance its relevance and impact on worker safety and health in the
context of engineered nanomaterials.
The research under this project will survey companies who
manufacture, distribute, fabricate, formulate, use or provide services
related to engineered nanomaterials. The analysis will describe the
survey sample, response rates, and types of company by industry and
size. Further analysis will focus on identifying the types of
engineered nanomaterials being used in industry and the types of
occupational safety and health practices being implemented. The
analysis will be used to develop a final report which evaluates the
influence of NIOSH products, services, and outputs on industry
occupational safety and health practices.
Under this project, the following activities and data collections
will be conducted:
(1) Company Pre-calls. Sampled companies will be contacted to
identify the person who will complete the survey and to ascertain
whether or not the company handles engineered nanomaterials.
(2) Survey. A web-based questionnaire, with a mail option, will be
administered to companies. The purpose of the survey is to learn
directly from companies about their use of NIOSH materials and their
occupational safety and health practices concerning engineered
nanomaterials.
A sample of 600 companies will be compiled from lists of industry
associations, research reports, marketing databases, and web-based
searches. Of the 600 selected companies we anticipate that 500 will
complete the survey within two years. The company pre-call is expected
to require five minutes to complete. The survey is expected to require
20 minutes to complete; including the time it may take respondents to
look-up and retrieve needed information. The estimated annualized
burden hours for the respondents' time to participate in this
information collection is 109 hours.
[[Page 32704]]
There are no costs to the responders other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Avgerage
Number of Number of burden per
Type of respondents Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Receptionist.......................... Pre-call................ 300 1 5/60
Occupational health and safety Survey.................. 100 1 20/60
specialists.
Industrial Production Managers........ Survey.................. 75 1 20/60
Natural Sciences Managers............. Survey.................. 75 1 20/60
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-14912 Filed 7-14-17; 8:45 am]
BILLING CODE 4163-18-P
